Therapy Areas: Inflammatory Diseases
8 April 2020 - - US-based clinical-stage biomedical company ProtoKinetix, Inc. (OTCQB: PKTX) having recently announced filing for patent protection for new applications of its AAGP (PKX-001) molecule,...
8 April 2020 - Biotech company Polaryx Therapeutics reported on Tuesday the receipt of approval from the US Food and Drug Administration (FDA) for Investigational New Drug Application (IND) of PLX-200...
7 April 2020 - - US-based ribonucleic acid interference therapeutics specialists Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), and Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA) have form...
3 April 2020 - Biopharmaceutical company Vanda Pharmaceuticals Inc (Nasdaq:VNDA) on Thursday launched the planned ODYSSEY VLY-686-3501 clinical study for the treatment and prevention of pneumonia asso...
2 April 2020 - United States-based Arena Pharmaceuticals Inc (Nasdaq: ARNA) has revealed positive top-line data from a Phase one clinical study assessing controlled-release delivery profiles for its i...
1 April 2020 - - Israel-based biotechnology company Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CFBI) is implementing an interim analysis of the Phase III Comfort trial designed to evaluate t...
Related Headlines